Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MineraloCOP: Hydrocortisone vs Prednisolone for AECOPD
NCT06892210Phase 4Recruiting
- Sponsor
- Copenhagen Respiratory Research
- Start
- Mar 2026
- Primary completion
- Aug 2030
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of hydrocortisone, methylprednisolone in chronic obstructive pulmonary disease (COPD), sponsored by Copenhagen Respiratory Research. Started Mar 2026; status: recruiting.
02
Drugs
hydrocortisonemethylprednisolone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT06892210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06892210.